Patent details

EP3283463 Title: DIMERIC QUINACRINE DERIVATIVES AS AUTOPHAGY INHIBITORS FOR CANCER THERAPY

Basic Information

Publication number:
EP3283463
PCT Application Number:
US2016027920
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP167809219
PCT Publication Number:
WO2016168721
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DIMERIC QUINACRINE DERIVATIVES AS AUTOPHAGY INHIBITORS FOR CANCER THERAPY
French Title of Invention:
DÉRIVÉS DIMÈRES DE LA QUINACRINE UTILISÉS EN TANT QU'INHIBITEURS DE L'AUTOPHAGIE POUR LA THÉRAPIE DU CANCER
German Title of Invention:
DIMERE QUINACRINDERIVATE ALS AUTOPHAGIEINHIBITOREN ZUR KREBSTHERAPIE
SPC Number:

Dates

Filing date:
26/04/2016
Grant date:
20/01/2021
EP Publication Date:
21/02/2018
PCT Publication Date:
20/10/2016
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
20/01/2021
EP B1 Publication Date:
20/01/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
26/04/2021
Expiration date:
26/04/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/01/2021
 
 

Name:
The Trustees of The University of Pennsylvania
Address:
3160 Chestnut Street Suite 200, Philadelphia, PA 19104, United States (US)

Inventor

1

Name:
WINKLER, Jeffrey
Address:
United States (US)

2

Name:
AMARAVADI, Ravi, K.
Address:
United States (US)

Priority

Priority Number:
201562148804 P
Priority Date:
17/04/2015
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/473; A61P 35/00; C07D 219/12;

Publication

European Patent Bulletin

Issue number:
202103
Publication date:
20/01/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages